Labs should demo real-world wins like new Alzheimer's drugs, not "book travel", says researcher

Afinetheorem · x · 2026-11-18

Responding to Miles Brundage's critique of OpenAI's ad messaging, the author advises lab comms teams: every new model release should demo concrete real-world impact — "GSK has a new Alzheimer's drug we helped develop" or "AI redid Seattle's traffic lights and cut commutes by X" — not "book travel," math proofs, or dystopia framing.

Original post →

More from AGI Musings

AGI Musings channel →